/ 2 items

#LFMD↓

LFMD/ 11/18/2025 · 11:27 AM

LifeMD Shares Tumble on Earnings Miss and GLP-1 Market Struggles

LifeMD stock plunged 25% after missing Q3 earnings and cutting guidance, citing fierce competition from low-cost compounded GLP-1 weight loss drugs despite Novo and Lilly partnerships.

LFMD/ 11/17/2025 · 8:56 AM

LifeMD Offers Lowest Cash-Pay Price for Wegovy & Ozempic at $199/Month

LifeMD now provides the lowest nationwide cash-pay price for Wegovy and Ozempic at $199/month for new patients, supporting more affordable access to GLP-1 weight-loss treatments.